Imperial College London Featured PhD Programmes
University of Hull Featured PhD Programmes
Life Science Zurich Graduate School Featured PhD Programmes

drug resistance PhD Projects, Programs & Scholarships

We have 101 drug resistance PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 101 drug resistance PhD Projects, Programs & Scholarships

PhD saved successfully

Faculty of Health and Medical Sciences Studentships

The University of Surrey's Faculty of Health and Medical Sciences (FHMS) is delighted to announce its new PhD studentship programme for 2022. Read more

NERC-funded PhD studentships: Centre for Environmental Policy, School of Public Health, Department of Surgery and Cancer, Imperial College London

The Science and Solutions for a Changing Planet (SSCP) Doctoral Training Partnership integrates six host partners and several business and policy sector partners, to offer an exciting programme that trains and inspires the next generation of environmental experts and leaders to address some of the toughest challenges of our time. Read more

Chemo-enzymatic Synthesis and Potential Applications of Novel antimicrobial peptides

Antimicrobial resistance (AMR) is rising to dangerously high levels in all parts of the world. In Europe alone, drug-resistant bacteria are estimated to cause 25,000 deaths annually and cost more than US$1.5 billion every year in healthcare expenses and productivity losses. Read more

(BBSRC DTP) A synthetic vaccine against the parasitic worm Schistosoma mansoni

Schistosomiasis is an infection caused by a parasitic blood flook, Schistosoma. Approximately 260 million people are estimated to carry the infection, mainly concentrated in low income countries, causing high levels of morbidity and mortality. Read more

Discovery of chemical and biological tools to probe hypoxic solid tumours

  Research Group: Institute of Cancer Therapeutics
A major challenge in cancer therapy is to develop therapeutic agents that selectively target tumour cells. One avenue towards the development of more selective cancer therapies is to exploit the unique physiological properties of solid tumours using prodrug approaches. Read more

Filtering Results